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1. Data description {#sec1}
===================

In this report, we present data on the infectious potential of TF and NT viruses generated from IFN-α treated primary CD4^+^ T cell cultures at different time points (3, 6, 9 and 12 days post infection). Resistance to IFN-α is believed to be an important property of HIV-1 isolates that establish new infection in the human host \[[@bib1]\]. Infectivity of TF and NT viruses was determined by infecting TZM-bl cells and measuring luciferase expression in terms of relative light units (RLU). The normalized RLU data obtained after deducting the background (cell control) value is presented in [Supplementary Table 1](#appsec1){ref-type="sec"}. TF viruses derived from both IFN-α treated and untreated CD4^+^ T cells were found to be more infectious than NT viruses derived from CD4^+^ T cell cultures grown under the same conditions ([Fig. 1](#fig1){ref-type="fig"}). Infectivity of TF viruses that were unexposed to IFN-α was found to be significantly higher than that of TF viruses grown from CD4^+^ T cell cultures exposed to IFN-α at all time points. On the other hand, the infectivity of NT viruses produced from IFN-α treated as well as untreated CD4^+^ T cells was not significantly different at any given time point. These findings indicate that TF viruses naturally possess enhanced resistance to IFN-α than NT viruses. The infectivity of TF and NT viruses exposed to IFN-α was similar at the earliest time point (day 3 post-infection), while that of TF viruses increased gradually with time (6, 9 and 12 days post-infection). The difference was statistically significant with p values of 0.015, 0.017 and 0.014 respectively as compared to NT variants.Fig. 1Infectivity of TF (a) and NT (b) viruses in TZM-bl cells. Infectious potential of chimeric TF and NT viruses derived from CD4^+^ T cells pre-treated with or without IFN-α at different time points was determined by measuring luciferase expression in TZM-bl cells after single round infection.Fig. 1

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Cells {#sec2.1}
----------

Primary CD4^+^ T cells were isolated from healthy donor peripheral blood mononuclear cells (PBMC) by negative selection using EasySep™ Human CD4^+^ T Cell Isolation Kit following the manufacturer\'s protocol. In brief, 5 × 10^7^ PBMCs/mL were mixed with the antibody coktail in PBS at a concentration of 50μl/mL. Non-CD4^+^ T cells labeled with antibodies and magnetic particles were separated using an EasySep™ magnet. The isolated CD4^+^ T cells were then stimulated with phytohemagglutinin (20 μg/mL) in the presence of 20 U/mL recombinant interleukin-2 (IL-2) in Rosewell Park Memorial Institute (RPMI) 1640 medium containing 10% (v/v) heat inactivated fetal bovine serum (FBS) (Sigma-Aldrich) at a concentration of 1 × 10^6^ cells per milliliter. TZM-bl indicator cell line (Lot number 150078) was maintained in Dulbecco\'s Modified Eagle medium (DMEM) with 10% FBS and 1% penicillin-streptomycin. Cells/cell lines were cultured at 37 °C with 5% CO~2~.

2.2. Virus production {#sec2.2}
---------------------

Chimeric TF and NT viruses were derived from infants who acquired infection through MTCT as described previously \[[@bib2]\]. The viruses were used to infect activated donor CD4^+^ T cells cultured in the presence or absence of IFN-α. Cell-free virus supernatants were collected at different time points (3, 6, 9- and 12-days post infection) and stored at −80 °C until use.

2.3. Luciferase expression {#sec2.3}
--------------------------

Virus supernatants collected at different time points were used to infect TZM-bl cells and viral infectivity was measured by quantifying luciferase expression using a Bright-Glo luciferase assay system (Promega) following the manufacturer\'s protocol. Briefly, TZM-bl cells were plated in a 96-well format (1 × 10^4^ cells/well) 24 hours before infection. At 48 hours post-infection, cells were lysed with 1X passive lysis buffer, and luciferase expression was measured in a luminometer and expressed as RLU. Data generated from the experiments were converted to logarithmic (log~10~) value before analysis. GraphPad Prism version 8 software was used for analysis and making of figure.
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